Trials / Sponsors / Travera Inc
Travera Inc
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Withdrawn | Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs Stage III Breast Cancer, Stage IV Breast Cancer, Stage III Lung Cancer | — | 2024-11-01 |
| Completed | Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx) Pleural Effusion, Malignant, Ascites, Malignant, Carcinoma | — | 2022-07-15 |
| Terminated | Mass Accumulation Rate (MAR) as a Predictive Biomarker in Multiple Myeloma Multiple Myeloma in Relapse | — | 2019-02-11 |